Conclusion In conclusion, compared with placebo or other interventions, GLP-1 receptor agonists did not increase or decrease the risk of thyroid cancer, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass and goiter
Semaglutide works by mimicking GLP-1 (glucagon-like peptide-1), a hormone that tells your brain youre full and slows down how quickly food leaves your stomach
Dr Christian Hendershot, director of the clinical and translational addiction research programme at the University of North Carolina at Chapel Hill, USA, said: We know that drugs in this class are remarkably effective for several important health outcomes many of which can influence longevity and quality of life.
One issue that I have come across is excessive pregnancy weight gain after stopping a weight loss medication for pregnancy, said Isaacs
Not covered